BUY Gland Pharma Limited — Rakesh Bansal
byRakesh BansalHorizon: NA (inferred 1–3 months)7 Jul 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·25 Jun · 4w ago
1 advisor has an active long-term BUY call on this stock
Advisor consensus · adjacent horizon·22 May · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services13 Oct 2026 · ~3 months · target ₹3,400 · Active
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Prakash Gaba7 Oct 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · SL hit
More from Rakesh Bansal
- BUY Federal Bank22 Oct 2026 · ~2 weeks · target ₹357 · Active
- BUY Bharti Airtel22 Oct 2026 · ~2 weeks · target ₹1,960 · Active
- SELL Eternal22 Oct 2026 · ~2 weeks · target ₹280 · Active
- BUY Tata Elxsi22 Oct 2026 · ~2 weeks · target ₹4,006 · Active
- BUY Infosys22 Oct 2026 · ~2 weeks · target ₹1,200 · SL hit

